STOCK OPTIONS, RESTRICTED STOCK AND WARRANTS (Tables)

3 Months Ended

Mar. 31, 2020

Share-based Payment Arrangement [Abstract]

Schedule of weighted-average assumptions

The following table presents the weighted-average assumptions used to estimate the fair value of the stock options granted during the three months ended March 31, 2020:

Risk Free Interest Rate		1.78	%
Expected Volatility		453.90	%
Expected Life (in years)		5.0
Dividend Yield		0	%
Weighted average estimated fair value of
options during the period	$	0.10

Schedule of stock option activity

	Options Outstanding
					Weighted -
					Average		Aggregate
					Remaining		Intrinsic
			Weighted-		Contractual		Value
	Number of		Average		Term		(in 000’s)
	Shares		Exercise Price		(in years)		(1)
Balance as of December 31, 2019	17,913,529		$0.12
Granted		4,700,000		0.07
Balance as of March 31, 2020		22,613,529	$	0.11
Exercisable as of March 31, 2020		20,088,529	$	0.11		2.9	$302

(1) The aggregate intrinsic value is calculated as the difference between the exercise price of the underlying awards and the quoted price of the Company’s common stock for options that were in-the-money at each respective period. 

Schedule of summary for the activities of unvested stock options

The following table summarizes the activities for the Company’s unvested stock options for the three months ended March 31, 2020:

	Unvested Options
	Weighted - Average
	Number of Unvested			Grant Date
	Options			Exercise Price
Balance as of December 31, 2019		1,000,000		$	0.20
Granted		4,700,000			0.07
Vested		(3,175,000	)		0.09
Balance as of March 31, 2020		2,525,000		$	0.09

Schedule of warrant activity

The following table summarizes the activities for the Company’s warrants for the three months ended March 31, 2020:

	Warrants Outstanding
	Number of Shares		Weighted-  Average Exercise Price		Weighted - Average Remaining  Contractual  Term in years)		Aggregate Intrinsic Value (in 000's) (1)
Balance as of December 31, 2019		22,262,608	$	0.31
Granted		24,900,000		0.15
Balance as of March 31, 2020		47,162,608	$	0.23		2.7
Exercisable as of March 31, 2020		47,162,608	$	0.23		2.7	$	-

(1) The aggregate intrinsic value is calculated as the difference between the exercise price of the underlying warrants and the closing stock price of $0.08 for our common stock on March 31, 2020.